Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Postbariatric Hypoglycemia ...

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean ...

NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...

However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which can lead to dizziness, cognitive impairment ...

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of ...

While insulin treatment in diabetic patients is extremely effective in lowering blood glucose from dangerous highs, the authors continued, episodes of moderate to severe hypoglycemia are common ...

‘Glucagon injectables were found to be a game-changer for preventing #hypoglycemia in diabetics. Say goodbye to low #bloodsugar worries! #diabetes #hypoglycemia’ To improve glucagon stability ...

Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

No. 48 / 2024Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinismU.S. Food and ...